412 results on '"Boveri, Emanuela"'
Search Results
2. Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity
3. Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis.
4. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
5. Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome
6. Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19
7. Wandering Spleen: An Unusual Cause of Recurrent Abdominal Pain
8. Clinical significance of somatic mutation in unexplained blood cytopenia
9. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
10. Arginase‐1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver
11. Clinical Implications of p53 Dysfunction in Patients with Myelodysplastic Syndromes
12. Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
13. Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms
14. Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma
15. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
16. The evolutionary journey from essential thrombocythaemia to acute erythroid leukaemia
17. Arginase‐1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver.
18. Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms
19. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström's macroglobulinemia and related lymphoid neoplasms
20. A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
21. A case of pediatric indolent systemic mastocytosis: The role of UVB‐NB phototherapy in the treatment of cutaneous lesions.
22. Distinctive Clinical and Histological Features of Waldenström's Macroglobulinemia and Splenic Marginal Zone Lymphoma
23. B Lymphoproliferative Neoplasms of Uncertain Biological Significance: Report from the IV Workshop of the Italian Group of Hematopathology and Review of the Literature.
24. Cutaneous lymphocytic vasculitis after administration of COVID ‐19 mRNA vaccine
25. Relationship between clone metrics and clinical outcome in clonal cytopenia
26. Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
27. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires
28. High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma
29. A dynamic prognostic model to predict survival in post–polycythemia vera myelofibrosis
30. Cutaneous involvement by post-polycythemia vera myelofibrosis
31. Acute megakaryoblastic leukemia with a novel GATA1 mutation in a second trimester stillborn fetus with trisomy 21
32. Systemic mastocytosis and lymphoplasmacytic lymphoma: an unusual and intriguing form of SM-AHN
33. Histopathological and immunohistochemical evaluation of bone marrow biopsy in myelodysplastic syndromes
34. Splenic marginal zone lymphoma: a prognostic model for clinical use
35. Nijmegen Breakage Syndrome-associated T-cell-rich B-cell Lymphoma: Case Report
36. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
37. Targeted next‐generation sequencing reveals molecular heterogeneity in non‐chronic lymphocytic leukemia clonal B‐cell lymphocytosis
38. Misdiagnosis of solid pseudopapillary neoplasm – a case report
39. CD3+ T large granular lymphocyte leukaemia in a HIV+, HCV+, HBV+ patient
40. Assessment of bone marrow involvement in non-Hodgkinʼs lymphomas: comparison between histology and flow cytometry
41. Targeted Next Generation Sequencing Reveals Molecular Heterogeneity in Non-CLL Clonal B-Cell Lymphocytosis
42. Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous disease
43. Aberrant phenotype of plasmacytoid monocytes in acute myeloid leukemia
44. Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations
45. Corrigendum: The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry (Future Oncology (2018) 14:26 (2713-2723) DOI: 10.2217/fon-2018-0291)
46. An Insidious Presentation of Splenic Marginal Zone Lymphoma
47. Jak2 (V617f) As An Acquired Somatic Mutation and A Secondary Genetic Event Associated With Disease Progression in Familial Myeloproliferative Disorders
48. Dyspnea Secondary to Pulmonary Hematopoiesis as Presenting Symptom of Myelofibrosis With Myeloid Metaplasia
49. Splenic and Nodal marginal zone lymphomas are indolent disorders at high hipatitis C virus seroprevalence with distinct presenting features but similar Morphologic and Phenotypic profiles
50. Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.